REY-GIRAUD AGNES
Known title: DirectorCIK: 0001235685
Associated companies
Transaction History
| GDRX | ▲ Buy | Grant | 73,434 | $0 | 6/16/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 192,185 | $90K | 3/12/2026 | View on chart |
| GDRX | ▼ Sell | Gift | 75,219 | $0 | 3/12/2026 | View on chart |
| GDRX | ▼ Sell | Gift | 75,219 | $0 | 3/12/2026 | View on chart |
| GDRX | ▼ Sell | Gift | 75,219 | $0 | 8/18/2025 | View on chart |
| GDRX | ▼ Sell | Gift | 75,219 | $0 | 8/18/2025 | View on chart |
| GDRX | ▲ Buy | Grant | 57,050 | $0 | 6/3/2025 | View on chart |
| GDRX | ▲ Buy | Grant | 2,464 | $0 | 7/8/2024 | View on chart |
| GDRX | ▲ Buy | Grant | 28,398 | $0 | 6/6/2024 | View on chart |
| GDRX | ▲ Buy | Grant | 39,177 | $0 | 6/14/2023 | View on chart |
| GDRX | ▲ Buy | Grant | 27,440 | $0 | 6/14/2022 | View on chart |
| GDRX | ▼ Sell | Open Market | 5,909 | $266K | 9/16/2021 | View on chart |
| GDRX | ▼ Sell | Other | 5,909 | $0 | 9/16/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 4,637 | $209K | 9/15/2021 | View on chart |
| GDRX | ▼ Sell | Other | 4,637 | $0 | 9/15/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 14,454 | $650K | 9/14/2021 | View on chart |
| GDRX | ▼ Sell | Other | 14,454 | $0 | 9/14/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 54,370 | $2.3M | 9/7/2021 | View on chart |
| GDRX | ▼ Sell | Other | 54,370 | $0 | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.